Nanocarriers for Drug-Targeting Brain Tumors
- 1st Edition - June 21, 2022
- Latest edition
- Editors: Lalit Kumar, Yashwant Pathak
- Language: English
Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and their design and development for targeting drugs to the brain. The book also presents case… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems.
Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.
Key features
Key features
- Provides information on the design and development of nanocarriers for targeting brain tumors
- Outlines the working principles of different nanocarriers for targeting brain tumors
- Includes case studies of different nanocarriers for targeting brain tumors
Readership
Readership
Table of contents
Table of contents
Part A Anatomy and physiology of the brain
1. An overview of the anatomy and physiology of the brain
2. Blood-brain barrier and central nervous system drug delivery: Opportunities and challenges
Part B Pharmacological and clinical problems
3.Challenges in targeting to brain and brain tumors
4. Potential targeting sites in brain and brain tumors
5. Drug resistance problems in chemotherapy
Part C Introduction and biomedical applications of nanocarriers
6. An overview on nanocarriers
7. Biomedical applications of nanocarriers in brain tumor targeting
Part D Lipophilic nanocarriers
8. Solid lipid nanoparticle-based drug delivery for targeting brain tumors
9. Nanostructured lipid carriers as an alternative carrier with high drug loading for targeting to brain tumors
10. Design, development, and mechanism of liposomes in drug targeting to brain tumors
11. Niosomes based drug delivery in targeting brain tumors
12. Nanoemulsions as effective carriers for targeting brain tumors
Part E Polymeric nanocarriers
13. Mechanism of polymeric micelles for drug targeting to brain tumors
14. Dendrimers as carriers for active targeting of brain tumors
15. Multifunctional polymeric nanocarriers for targeting and treatment of brain tumors
16. Polymersomes for targeting to brain tumors
Part F Metallic nanocarriers systems
17. Development and applications of gold nanoparticles for drug targeting to brain tumors
18. Gold nanoparticles in cancer theranostics
19. Targeting of silver nanoparticles to brain tumors
Part G Hybrid nanocarriers
20. Hybrid nanoparticles to cross the blood–brain barrier
21. Targeting of lipid-polymer (hybrid) nanoparticles to brain tumors
22. Nano-enabled systems for neural tissue regenerative applications
23. Multifunctional liposome-quantum dot hybrid nanocarriers for drug targeting to brain tumors
24. Drug-loaded nanoclusters for brain targeting
25. Nano-enabled platforms for tropical diseases affecting the CNS
26. Phytoconstituents in brain delivery using nanodrug delivery
27. Multifunctional nanocarrier systems targeting brain tumors: A review
Part H Future directions and toxic concerns
28. Expert opinion on current challenges and future directions related to nanocarriers for drug targeting to the brain
29. Biological nanodrugs for brain targeting
Product details
Product details
- Edition: 1
- Latest edition
- Published: June 23, 2022
- Language: English
About the editors
About the editors
LK
Lalit Kumar
YP
Yashwant Pathak
Yashwant Pathak, is Professor, Taneja College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is nanotechnology, drug delivery systems and nutraceuticals. He is also Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.